OFM
Omega Fund Management Portfolio holdings
AUM
$222M
1-Year Est. Return
9.71%
1 Year Est. Return
+9.71%
AUM
$222M
AUM Growth
+$67.9M
(+44%)
Holding
14
Top Sells
| 1 | +$12.8M | |
| 2 | +$8.18M | |
| 3 | +$7.23M | |
| 4 |
Lexeo Therapeutics
LXEO
|
+$4.76M |
| 5 |
BBNX
Beta Bionics
BBNX
|
+$1.35M |
Sector Composition
| 1 | Healthcare | 99.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KMTS
1
Kestra Medical Technologies
KMTS
$1.43B
| $39.1M | 17.59% |
1,645,893
|
|
||
|
BBNX
2
Beta Bionics
BBNX
$1.29B
| $38.2M | 17.16% |
1,920,125
-68,162
|
|
||
|
BBOT
3
BridgeBio Oncology
BBOT
$1.03B
| $38.1M | 17.13% |
+3,289,661
|
|
||
|
BCAX
4
Bicara Therapeutics
BCAX
$1.05B
| $34.8M | 15.66% |
2,204,650
|
|
||
5
Nuvation Bio
NUVB
$2.84B
| $32.7M | 14.69% |
8,831,089
-2,211,639
|
|
||
|
UPB
6
Upstream Bio Inc
UPB
$1.55B
| $25.5M | 11.47% |
1,356,293
-680,000
|
|
||
|
IMA
7
ImageneBio Inc
IMA
$71.9M
| $3.71M | 1.67% |
455,361
+267,934
|
|
||
8
enGene Holdings
ENGN
$597M
| $3.6M | 1.62% |
526,357
|
|
||
9
Sana Biotechnology
SANA
$1.32B
| $3M | 1.35% |
843,750
|
|
||
|
ALMS
10
Alumis Inc
ALMS
$1.26B
| $2.61M | 1.17% |
653,223
|
|
||
11
Replimune Group
REPL
$774M
| $1.04M | 0.47% |
248,672
-1,726,531
|
|
||
|
12
enGene Holdings Warrants
ENGNW
$29.8M
| $63.4K | 0.03% |
89,702
-231,800
|
|
||
13
Immunic
IMUX
$78.9M
| – | – |
-1,788,160
|
|
||
|
14
Lexeo Therapeutics
LXEO
$715M
| – | – |
-1,184,636
|
|